Drug Type Monoclonal antibody |
Synonyms MSM 605, MSM605 |
Target |
Action modulators |
Mechanism GPCR modulators(G-protein coupled receptor modulators) |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Asthma | Preclinical | United States | 30 Jan 2022 | |
| Pulmonary Disease, Chronic Obstructive | Preclinical | United States | 30 Jan 2022 | |
| Respiratory Syncytial Virus Infections | Preclinical | United States | 30 Jan 2022 |






